EICHOR
● Completed
High-dose Cephalexin for Cellulitis (HI-DOCC)
Condition: Cellulitis · Sponsor: Ottawa Hospital Research Institute
About this study
Cellulitis is a common condition diagnosed and managed in the ED that carries significant burden on healthcare systems globally. Cellulitis is the 8th most common reason patients present to an ED in Canada. Among middle-aged patients (45-64 years) it is the 5th most common reason to visit an ED. This disease is responsible for significant healthcare system burden due to high hospitalization rates and subsequent costs. The Investigators conducted a health records review at two large urban EDs in Ottawa, and found that 29.6% of patients with cellulitis are admitted to hospital. In a separate study, The investigators found that the mean cost of care to hospitalize cellulitis patients for IV antibiotics was $10,145 CDN.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (10)
| South Health Campus | Calgary, Alberta, Canada | — |
| Queen Elisabeth II Health Sciences Centre | Halifax, Nova Scotia, Canada | — |
| Health Sciences North | Greater Sudbury, Ontario, Canada | — |
| Kingston Health Sciences Centre | Kingston, Ontario, Canada | — |
| London Health Sciences Centre | London, Ontario, Canada | — |
| The Ottawa Hospital | Ottawa, Ontario, Canada | — |
| Thunder Bay Health Sciences Centre | Thunder Bay, Ontario, Canada | — |
| Sinai Health System | Toronto, Ontario, Canada | — |
| Hôpital du Sacré-Cœur de Montréal | Montreal, Quebec, Canada | — |
| Enfant-Jésus Hospital | Québec, Quebec, Canada | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05852262